Polymorphic and amorphous salt forms of squalamine dilactate

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7981876
SERIAL NO

11410098

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dilactate salt of squalamine and their utility in inhibiting neovascularization and endothelial cell proliferation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ENTERIN INC2005 MARKET STREET SUITE 3125 PHILADELPHIA PA 19103

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Armbruster, Kyle Plymouth Meeting, US 2 20
Chellquist, Eric Plymouth Meeting, US 3 22
Doubleday, Mary Plymouth Meeting, US 5 60
Gilbert, Charles Plymouth Meeting, US 16 435
Levitt, Roy C Plymouth Meeting, US 20 118
McLane, Michael Plymouth Meeting, US 26 107
Zhang, Xuehai Plymouth Meeting, US 15 87

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation